TTY Biopharm Co Ltd (4105) — Capital Reinvestment Ratio
Latest as of December 2025:
0.04x
TTY Biopharm Co Ltd (4105) has a Capital Reinvestment Ratio of 0.04x as of December 2025, meaning it reinvests 0% of its operating cash flow (NT$778.89 Million) in capital expenditures (NT$34.72 Million). See 4105 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.04x
Capex / Operating Cash Flow
Operating Cash Flow
NT$778.89 Million
TWD
Capital Expenditures
NT$34.72 Million
TWD
Data as of
Dec 2025
Most recent filing
TTY Biopharm Co Ltd Capital Reinvestment Ratio (2017–2025)
This chart tracks TTY Biopharm Co Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for TTY Biopharm Co Ltd (2017–2025)
Year-by-year Capital Reinvestment Ratio for TTY Biopharm Co Ltd from 2017 to 2025. For live market cap and broader valuation context, see market cap of TTY Biopharm Co Ltd.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.09x | NT$1.76 Billion | NT$150.83 Million | ▼ -14.0% |
| 2024 | 0.10x | NT$1.35 Billion | NT$134.29 Million | ▲ +8.5% |
| 2023 | 0.09x | NT$1.09 Billion | NT$99.58 Million | ▼ -16.3% |
| 2022 | 0.11x | NT$1.24 Billion | NT$135.50 Million | ▲ +85.8% |
| 2021 | 0.06x | NT$1.26 Billion | NT$74.15 Million | ▼ -82.9% |
| 2020 | 0.35x | NT$526.35 Million | NT$181.86 Million | ▲ +498.3% |
| 2019 | 0.06x | NT$1.21 Billion | NT$69.86 Million | ▼ -16.3% |
| 2018 | 0.07x | NT$1.07 Billion | NT$74.09 Million | ▼ -29.0% |
| 2017 | 0.10x | NT$996.52 Million | NT$96.79 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow